Dr. Neumann graduated from the Wake Forest University School of Medicine in 1973. He works in Glenview, IL and specializes in Gastroenterology and Internal Medicine. Dr. Neumann is affiliated with Glenbrook Hospital, Highland Park Hospital, Northshore University Health System Evanston Hospital and Northshore University HealthSystem.
Dr. Neumann graduated from the Creighton University School of Medicine in 1984. He works in Cottonwood, AZ and 1 other location and specializes in Nephrology and Internal Medicine. Dr. Neumann is affiliated with Flagstaff Medical Center, Verde Valley Medical Center, Yavapai Regional Medical Center East and Yavapai Regional Medical Center West.
Medical School University of Texas Medical Branch at Galveston Graduated: 1980
Languages:
English Spanish
Description:
Dr. Neumann graduated from the University of Texas Medical Branch at Galveston in 1980. He works in Lubbock, TX and 3 other locations and specializes in Radiation Oncology. Dr. Neumann is affiliated with Covenant Medical Center, Plains Regional Medical Center and University Medical Center.
Madison Parish Hospital Rural Health Clinic 808 Johnson St, Tallulah, LA 71282 318 574-5080 (phone), 318 574-3805 (fax)
Education:
Medical School Louisiana State University School of Medicine at New Orleans Graduated: 1968
Languages:
English
Description:
Dr. Neumann graduated from the Louisiana State University School of Medicine at New Orleans in 1968. He works in Tallulah, LA and specializes in Family Medicine. Dr. Neumann is affiliated with Madison Parish Hospital.
Microvessel networks are produced in vitro from tissue-engineered parent vessels sprouting into a supporting matrix, as for example gels, of extracellular matrix proteins. The microvessel systems are integrated into devices that allow for controlled perfusion with fluids. The vessels may include cells from one cell type, for example, endothelial cells, or from combinations of two or more cell types.
In one aspect, the invention provides methods for forming a target tissue substitute. The methods of the invention comprise the following steps: (a) providing a scaffold comprising one or more layers of one or more arrays of microfibers, wherein one or more of the arrays of microfibers is designed to mimic the configuration of one or more structural elements in a target tissue; and (b) culturing cells on the scaffold to form a target tissue substitute. In another aspect, the invention provides implantable medical devices. The implantable medical devices of the invention comprise a scaffold comprising one or more layers of one or more arrays of microfibers, wherein one or more of the arrays of microfibers is arranged to mimic the configuration of one or more structural elements in a target tissue. Typically, cells are cultured on the scaffold to form a target tissue substitute.
Mark E. Fauver - Seattle WA, US Eric J. Seibel - Seattle WA, US Michael G. Meyer - Seattle WA, US Alan C. Nelson - Gig Harbor WA, US J. Richard Rahn - Sammamish WA, US Thomas Neumann - Seattle WA, US Roger H. Johnson - Phoenix AZ, US
Assignee:
University of Washington - Seattle WA Visiongate, Inc. - Pheonix AZ
International Classification:
G06K 9/00
US Classification:
382131, 382132
Abstract:
An optical tomography system for imaging an object of interest including a light source for illuminating the object of interest with a plurality of radiation beams. The object of interest is held within an object containing tube such that it is illuminated by the plurality of radiation beams to produce emerging radiation from the object containing tube, a detector array is located to receive the emerging radiation and produce imaging data used by a mechanism for tracking the object of interest.
Method For Creating Perfusable Microvessel Systems
A method for creating networks of perfusable microvessels in vitro. A mandrel is drawn through a matrix to form a channel through the matrix. Cells are injected into the channel. The matrix is incubated to allow the cells to attach inside the channel. The channel is perfused to remove unattached cells to create a parent vessel, where the parent vessel includes a perfusable hollow channel lined with cells in the matrix. The parent vessel is induced to create sprouts into the surrounding matrix gel so as to form a microvessel network. The microvessel network is subjected to luminal perfusion through the parent vessel.
Method For Creating Perfusable Microvessel Systems
Thomas Neumann - Seattle WA, US Anna Tourovskaia - Mountlake Terrace WA, US Mark E. Fauver - Seattle WA, US Julia Oi Yan Yu - Kirkland WA, US
Assignee:
Nortis, Inc. - Seattle WA
International Classification:
C12N 5/07
US Classification:
435395, 435325, 435397
Abstract:
A method for creating networks of perfusable microvessels in vitro. Cells including cell types capable of sprouting are seeded into a channel in a matrix at to activate competency of the cells for sprouting as microvessels based on the seeding density. The matrix channel is perfused with medium to allow parent vessels to form and for viability. The parent vessels and matrix are incubated and perfused to provide for sprouting of microvessels from parent vessels into the surrounding matrix. The sprouting parent vessels are grown until network forms.
Method For Creating Perfusable Microvessel Systems
Creating a tissue structure in vitro includes juxtaposing mandrels on a culture/perfusion device frame where the mandrels are spaced apart substantially parallel to each other and connecting the mandrels to tubes including an upstream tubes and downstream tubes. The upstream tubes are connected with an upstream manifold and the downstream tubes are connected to a downstream manifold. The frame and the mandrels are sterilized, coated and seeded with cells that multiply and form circular layers around each of the mandrels until the circular layers merge into a tissue structure which is subjected to a growth medium. The mandrels are extracted and the tissue structure is perfused.
Functional Imaging Of Cells With Optical Projection Tomography
Michael G. Meyer - Phoenix AZ, US J. Richard Rahn - Sammamish WA, US Anna V. Tourovskaia - Mountlake Terrace WA, US Julia Oi Yan Yu - Santa Clara CA, US Christy A. Lancaster - Seattle WA, US Thomas Neumann - Seattle WA, US Mark E. Fauver - Seattle WA, US
International Classification:
H04N 13/02
US Classification:
348 50, 348E13074
Abstract:
A method for 3D imaging of a biologic object () in an optical tomography system where a subcellular structure of a biological object () is labeled by introducing at least one nanoparticle-biomarker. The labeled biological object () is moved relatively to a microscope objective () to present varying angles of view and the labeled biological object () is illuminated with radiation having wavelengths between 150 nm and 900 nm. Radiation transmitted through the labeled biological object () and the microscope objective () within at least one wavelength bands is sensed with a color camera, or with a set of at least four monochrome cameras. A plurality of cross-sectional images of the biological object () from the sensed radiation is formed and reconstructed to make a 3D image of the labeled biological object ().
in graduate school in the late 1980s and early '90s when he first heard stories about the 200 men who once lived embedded in the ice of Greenland. He didn't pay those tales much attention until 2010, when he and Thomas Neumann, a UVM colleague, got hold of some of the original samples from Colorado.
Date: Oct 11, 2023
Category: Science
Source: Google
Opel CEO Neumann resigns ahead of sale to PSA Group
Adam Opel GmbH said in a statement Monday that Karl-Thomas Neumann would leave his post as head of GM's European carmaker immediately. He will remain a member of top Opel management until the sale to PSA Group goes through.
Date: Jun 12, 2017
Category: Business
Source: Google
Fiat Predicts VW Proposal as Opel Sale Seen Spurring Car Deals
Teaming up with PSA offers many opportunities to share costs in areas including vehicle development and purchasing, said Opel Chief Karl-Thomas Neumann, who will stay on after the deal is completed. We know weve got a lot of work ahead of us.
Date: Mar 07, 2017
Category: Business
Source: Google
PSA May Vow to Maintain Opel Sites as Chief Tours for Support
Tavares plans to expand the Opel brand internationally,German car magazine Automobilwoche reported Saturday. Opel chief Karl-Thomas Neumann said in a letter to his employees on Friday that the companys works council and IG Metall union are closely involved in the potential deal.
The noise was Opel's Ampera-e all-electric compact car, driven on stage by the company's CEO, Karl-Thomas Neumann. The Ampera-e is the European equivalent of the Chevrolet Bolt, and will go on sale sometime in the first half of next year.
Girsky spent the next 22 months scrambling to stabilize Opel, eventually hiring current Opel CEO Karl-Thomas Neumann, in early 2013. Girsky and Neumann are credited with putting Opel on a path to recovery. Its market share rose in 2013 -- the first time in 14 years -- and again in 2014. GMs Europea
Date: Apr 22, 2016
Category: Business
Source: Google
Business ponders 'horrific' cost of end to borderless Europe
"A breakdown of Schengen would be horrific for us," carmaker Opel's chief executive, Karl-Thomas Neumann, told reporters on Tuesday, noting Opel depends on the reliable transport of goods and components from Germany, Spain, Poland, Britain and Italy.
Date: Mar 02, 2016
Category: Business
Source: Google
Detroit motor show finds unsure footing in Middle America
the Bolt yet, but its hard to believe it wont do so. The company got its fingers burned by almost non-existent sales of the Opel Ampera (a plugin hybrid based on the Chevrolet Volt) so hasnt yet given a solid yes or no on the Bolt, but Opel CEO Karl-Thomas Neumann recently told insideevs.com that